Pathophysiology of Neurodegenerative Diseases

Marceline Hayes
3 min readAug 29, 2023

--

Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of neurons in the Central Nervous System (CNS) and, in some cases, the peripheral nervous system. This leads to a decline in cognitive function, movement, and other bodily functions.

The pathophysiology of neurodegenerative diseases is complex and not fully understood. The pathophysiology of neurodegenerative diseases is the study of the underlying biological mechanisms that cause these diseases. It is a complex and active area of research, and there is still much that is not known.

These conditions include Alzheimer’s disease, marked by memory loss and cognitive decline; Parkinson’s disease, associated with tremors and motor impairment; Huntington’s disease, causing involuntary movements and cognitive decline; Amyotrophic Lateral Sclerosis (ALS), leading to muscle weakness and paralysis; and several others like Frontotemporal Dementia, Multiple System Atrophy, and Progressive Supranuclear Palsy. These diseases often share common features such as

Abnormal protein folding and aggregation: A number of neurodegenerative diseases are characterized by the accumulation of abnormal proteins in the brain. These proteins can fold abnormally and form aggregates. These aggregates can damage neurons and lead to their death. Examples include amyloid-beta plaques in Alzheimer’s disease and alpha-synuclein aggregates in Parkinson’s disease.

Expansion of polyglutamine (polyQ) tracts in proteins results in protein aggregation

Oxidative stress: Increased production of reactive oxygen species (ROS) can lead to oxidative stress, damaging cellular components like lipids, proteins, and DNA. Oxidative stress disrupts cellular homeostasis and contributes to neuronal dysfunction and death. Mitochondrial dysfunction, impaired antioxidant defense mechanisms, and impaired protein degradation pathways contribute to oxidative stress in neurodegenerative diseases.

Oxidative stress

Neuroinflammation: Neuroinflammation, characterized by the activation of immune cells and the release of pro-inflammatory molecules, is a common feature of neurodegenerative diseases.

Mitochondrial dysfunction: Mitochondria are the cells’ “powerhouses” and are responsible for producing energy. Dysfunction in these energy-producing organelles can lead to energy deficits, impaired calcium homeostasis, and increased ROS production, all of which contribute to neuronal degeneration.

Excitotoxicity: Excessive stimulation of neurons by neurotransmitters, particularly glutamate, can lead to a phenomenon called excitotoxicity. This results in an influx of calcium ions into neurons, leading to cell damage and death. Excitotoxicity is implicated in diseases like Alzheimer’s disease and Huntington’s disease.

Synaptic loss: Synapses are the connections between neurons. Synapse loss has been linked to a number of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.

Tauopathy: Tau is a protein that helps to stabilize microtubules, which are structures that support the shape and function of neurons. Tauopathy is a condition in which tau becomes abnormally phosphorylated and forms aggregates. These aggregates can damage neurons and lead to their death.

Amyloidosis: Amyloid is a type of protein that can aggregate and form plaques. These plaques can damage neurons and lead to their death.

Genetics: Some neurodegenerative diseases are caused by mutations in specific genes. For example, mutations in the APP gene are responsible for Alzheimer’s disease.

Environmental factors: Exposure to certain environmental toxins, such as pesticides, has been linked to an increased risk of developing neurodegenerative diseases.

The research on the pathophysiology of neurodegenerative diseases is ongoing, and there is still much that is not known. However, the research that has been done has helped identify some of the key biological mechanisms that are involved in these diseases. This knowledge is essential for developing new treatments and prevention strategies. In upcoming posts, we will continue to talk about the symptoms, treatments, and prevention of each neurodegenerative disease. Stay tuned!

--

--

Marceline Hayes

I'm Marceline Hayes, who has a passion that revolves around the intricate world of neuroscience.